Evidence map›Paper›PMID 25416041›Full record

SynthesisEuropean journal of preventive cardiology2016

Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.

Peter Willeit, Simon G Thompson, Stefan Agewall, Göran Bergström, Horst Bickel, Alberico L Catapano, Kuo-Liong Chien, Eric de Groot, Jean-Philippe Empana, Thorleif Etgen and 45 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in European journal of preventive cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023
    Article
  16. Article
  17. Article
  18. Predicting value of fibrinogen in identifying cerebrovascular ischemic events in patients with dizziness/vertigo.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors.

Peter WilleitThe Department of Public Health and Primary Care, University of Cambridge, UK Department of Neurology, Medical University Innsbruck, Austria.
Simon G ThompsonThe Department of Public Health and Primary Care, University of Cambridge, UK.
Stefan AgewallInstitute of Clinical Sciences, University of Oslo, and the Department of Cardiology, Oslo University Hospital Ullevål, Norway.
Göran BergströmWallenberg Laboratory for Cardiovascular Research, University of Gothenburg, Sweden.
Horst BickelDepartment of Psychiatry and Psychotherapy, University Hospital of the Technische Universität München, Germany.
Alberico L CatapanoDepartment of Pharmacological Sciences, University of Milan, and IRCSS Multimedica Sesto S Giovanni, Milan, Italy.
Kuo-Liong ChienInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan Department of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Eric de GrootAcademic Medical Centre, Cardiology and Thoracic Surgery, and Imagelabonline and Cardiovascular, Amsterdam, The Netherlands.
Jean-Philippe EmpanaINSERM, U970, Université Paris Descartes, France.
Thorleif EtgenDepartment of Neurology, Kliniken Südostbayern, Klinikum Traunstein, Germany.
Oscar H FrancoDepartment of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
Bernhard IglsederDepartment of Geriatric Medicine, Paracelsus Medical University, and the Gemeinnützige Salzburger Landeskliniken Betriebsgesellschaft GmbH, Christian-Doppler-Klinik, Salzburg, Austria.
Stein H JohnsenDepartment of Neurology and Neurophysiology, University Hospital of Northern Norway, and the Department of Clinical Medicine, University of Tromsø, Tromsø, Norway.
Maryam KavousiDepartment of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
Lars LindDepartment of Medicine, Uppsala University, Sweden.
Jing LiuDepartment of Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, PR China.
Ellisiv B MathiesenDepartment of Neurology and Neurophysiology, University Hospital of Northern Norway, and the Department of Clinical Medicine, University of Tromsø, Tromsø, Norway.
Giuseppe D NorataDepartment of Pharmacological Sciences, University of Milan, and the SISA Centre for the Study of Atherosclerosis, Bassini Hospital, Cinisello Balsamo, Italy.
Michael H OlsenDepartment of Endocrinology, Centre for Individualized Medicine in Arterial Diseases, Odense University Hospital, Denmark.
Aikaterini PapagianniDepartment of Nephrology, Aristotle University of Thessaloniki, Hippokration General Hospital, Greece.
Holger PoppertDepartment of Neurology, University Hospital of the Technische Universität München, Germany.
Jackie F PriceCentre for Population Health Sciences, University of Edinburgh, UK.
Ralph L SaccoDepartment of Neurology, Miller School of Medicine, University of Miami, FL, USA.
David N YanezDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Dong ZhaoDepartment of Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, PR China.
Ulf SchminkeDepartment of Neurology, Greifswald University Clinic, Germany.
Alpaslan BülbülDepartment of Neurology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Joseph F PolakTufts University School of Medicine, Tufts Medical Center, Boston, MA, USA.
Matthias SitzerDepartment of Neurology, University Hospital Frankfurt, Frankfurt am Main, Germany Department of Neurology, Klinikum Herford, Germany.
Albert HofmanDepartment of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Liliana GrigoreDepartment of Pharmacological Sciences, University of Milan, and the SISA Centre for the Study of Atherosclerosis, Bassini Hospital, Cinisello Balsamo, Italy.
Marcus DörrDepartment B for Internal Medicine, University Medicine Greifswald, and the German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Germany.
Ta-Chen SuDepartment of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Pierre DucimetièreUniversity Paris Sud-XI, Kremlin-Bicêtre, France.
Wuxiang XieDepartment of Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, PR China.
Kimmo RonkainenInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Stefan KiechlDepartment of Neurology, Medical University Innsbruck, Austria.
Tatjana RundekDepartment of Neurology, Miller School of Medicine, University of Miami, FL, USA.
Christine RobertsonCentre for Population Health Sciences, University of Edinburgh, UK.
Björn FagerbergWallenberg Laboratory for Cardiovascular Research, University of Gothenburg, Sweden.
Lena BokemarkWallenberg Laboratory for Cardiovascular Research, University of Gothenburg, Sweden.
Helmuth SteinmetzDepartment of Neurology, University Hospital Frankfurt, Frankfurt am Main, Germany.
M Arfan IkramDepartment of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
Henry VölzkeInstitute for Community Medicine, SHIP/Clinical-Epidemiological Research, Greifswald, Germany.
Hung-Ju LinDepartment of Internal Medicine, National Taiwan University, Taipei, Taiwan Health Management Centre, National Taiwan University Hospital, Taipei, Taiwan.
Matthieu PlichartINSERM, U970, Université Paris Descartes, France Gerontology Department, Broca Hospital, Paris, France.
Tomi-Pekka TuomainenInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Moise DesvarieuxDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA, and the École des Hautes Études en Santé Publique, and INSERM U738, Paris, France.
Stela McLachlanCentre for Population Health Sciences, University of Edinburgh, UK.
Caroline SchmidtWallenberg Laboratory for Cardiovascular Research, University of Gothenburg, Sweden.
Jussi KauhanenInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Johann WilleitDepartment of Neurology, Medical University Innsbruck, Austria.
Matthias W LorenzDepartment of Neurology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Dirk SanderDepartment of Neurology, Benedictus Krankenhaus Tutzing and Feldafing, Tutzing, Germany and Technische Universität München, Germany D.Sander@mac.com.
PROG-IMT study group

Funding

ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKER01DE013094 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DESVARIEUX, MOISE · 2000 to 2016
$14.4M
Stroke Incidence and Risk Factors in a Tri-Ethnic RegionR37NS029993 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ELKIND, MITCHELL S, SACCO, RALPH L. · 2008 to 2014
$12.1M
Exceptional Survival: Trajectories to Functional Aging (CHS All Stars)R01AG023629 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEWMAN, ANNE B. · 2004 to 2016
$9.5M
CHS Events Follow-up StudyR01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2009 to 2014
$6.3M
CHS Events Follow-up StudyU01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2005 to 2008
$4.6M
Role of EIIIA fibronectin in pulmonary fibrosisR01HL085083 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WHITE, ERIC S · 2007 to 2011
$1.9M
CHS-Transition PhaseN01HC55222 · NHLBI · PI , · 2007 to 2007
$575k
Exceptional Survival: Trajectories to Functional Aging (CHS All Stars)R56AG023629 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEWMAN, ANNE B. · 2010 to 2010
$300k
CHS-ULTRASOUND READINGN01HC045133 · HC · GEISINGER HEALTH SYSTEM · PI O'LEARY, DANIEL H. · 1994 to 2000
$155k
CENTRAL BLOOD ANALYSIS LABORATORY FOR CHSN01HC085086 · HC · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TRACY, RUSSELL P · 1988 to 2000
–
CORONARY HEART DISEASE AND STROKE IN PEOPLE AGED 65-84N01HC085085 · HC · NEW ENGLAND DEACONESS HOSPITAL · PI O'LEARY, DANIEL · 1988 to 1993
–
CHS-Transition Phase -268055222-268055222N01HC055222 · HC · UNIVERSITY OF WASHINGTON · PI KRONMAL, RICHARD A · 2005 to 2006
–
British Heart Foundation RG/08/014/24067Medical Research Council MR/L003120/1NHLBI NIH HHS HHSN268200800007CNHLBI NIH HHS HHSN268201200036CNHLBI NIH HHS HL080295NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC045133NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085084NHLBI NIH HHS N01 HC085085NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01HC35129NHLBI NIH HHS N01HC45133NHLBI NIH HHS N01 HC55222NHLBI NIH HHS N01HC85084NHLBI NIH HHS N01HC85085NHLBI NIH HHS R01 HL080295NHLBI NIH HHS U01 HL080295NIA NIH HHS AG023629NIA NIH HHS R01 AG023629NIA NIH HHS R56 AG023629NIDCR NIH HHS R01 DE013094NINDS NIH HHS R37 NS 029993NINDS NIH HHS R37 NS029993
6 · The paper itself

Abstract

backgroundLarge-scale epidemiological evidence on the role of inflammation in early atherosclerosis, assessed by carotid ultrasound, is lacking. We aimed to quantify cross-sectional and longitudinal associations of inflammatory markers with common-carotid-artery intima-media thickness (CCA-IMT) in the general population.

methodsInformation on high-sensitivity C-reactive protein, fibrinogen, leucocyte count and CCA-IMT was available in 20 prospective cohort studies of the PROG-IMT collaboration involving 49,097 participants free of pre-existing cardiovascular disease. Estimates of associations were calculated within each study and then combined using random-effects meta-analyses.

resultsMean baseline CCA-IMT amounted to 0.74 mm (SD = 0.18) and mean CCA-IMT progression over a mean of 3.9 years to 0.011 mm/year (SD = 0.039). Cross-sectional analyses showed positive linear associations between inflammatory markers and baseline CCA-IMT. After adjustment for traditional cardiovascular risk factors, mean differences in baseline CCA-IMT per one-SD higher inflammatory marker were: 0.0082 mm for high-sensitivity C-reactive protein (p < 0.001); 0.0072 mm for fibrinogen (p < 0.001); and 0.0025 mm for leucocyte count (p = 0.033). 'Inflammatory load', defined as the number of elevated inflammatory markers (i.e. in upper two quintiles), showed a positive linear association with baseline CCA-IMT (p < 0.001). Longitudinal associations of baseline inflammatory markers and changes therein with CCA-IMT progression were null or at most weak. Participants with the highest 'inflammatory load' had a greater CCA-IMT progression (p = 0.015).

conclusionInflammation was independently associated with CCA-IMT cross-sectionally. The lack of clear associations with CCA-IMT progression may be explained by imprecision in its assessment within a limited time period. Our findings for 'inflammatory load' suggest important combined effects of the three inflammatory markers on early atherosclerosis.

Indexed as

Disease ProgressionLeukocyte CountAtherosclerosisBiomarkersCarotid Intima-Media ThicknessC-Reactive ProteinFibrinogenHumansInflammationBiomarkersC-Reactive ProteinFibrinogenatherosclerosisInflammationmeta-analysis

Identifiers

PMID25416041
PMCPMC4544641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.